ecorn-cf: App. question single

User login

Enter your username and password here in order to log in on the website:

Please note: While some information will still be current in a year, other information may already be out of date in three months time. If you are in any doubt, please feel free to ask.

POTENTIATOR / GALAPAGOS

Question: Hello

An article published on 12/16/13 indicates that the biotechnology company Galapagos has a new drug candidate (potentiator) which will be tested in clinical trials.
How much credit can you give to this notification?
Have you more information?
Thanks
Answer: Hello

We have no additional information other than this press release (which you refer) published on 16/12 on the company website.
Galapagos is a company known in the pharmaceutical world, we can trust to this information regarding a new drug candidate (GLPG1837) and we can wait for the announcement of a new clinical trial.
Best regards,

Anna Ronayette; 08.01.2014

ECORN-CF European Centers of Reference Network for Cystic Fibrosis

The expert advice can not make a diagnosis or provide individual recommendations for a therapy. The information given in the expert advice does not replace a medical consultation or treatment. The content of the expert advice cannot be used for making a diagnosis on your own or for a decision regarding the choice and application of treatment methods. Please read also the detailed terms of use with disclaimer.

ECORN-CF is kindly sponsored by:

We comply with the HONcode standard for trustworthy health information: verify here.